Seven & i Eyes Żabka Stake in Major European Expansion Push 
Uber to Acquire Delivery Hero in $14.8 Billion Deal to Expand Global Food Delivery Business 
Stripe, Advent Offer Over $53 Billion to Acquire PayPal in Major Fintech Deal 
KAIST, Stanford Develop Self-Dressing Robot for Cleanrooms and Emergency Gear 
Hyundai Takes Full Control of Boston Dynamics to Accelerate Humanoid Robot and AI Strategy 
Volkswagen Launches €28,000 ID. Cross EV as Europe’s Electric Vehicle Demand Accelerates 
Volvo Cars Q2 Profit Falls as Automaker Bets on EX60 EV to Drive Recovery 
Mikron H1 2026 Sales Fall 5.9% as Automation Weakness Weighs on Profit 
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings 
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
xAI Sues Man for Allegedly Using Grok to Generate AI Child Abuse Deepfakes 
SEB Q2 Profit Rises on Strong Lending, Record Fee Income, Announces New Share Buyback 
Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features 
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 
Trump Slams New York Data Center Ban, Warns AI Investment Could Shift to Other States 
NTSB Leads Investigation Into Ryanair Boeing 737 Engine Failure Over Greece 
Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI 
Samsung Electonics’ Galaxy smartwatches are being put in the spotlight after a recent study shows it can help people suffering from Parkinson’s disease. It was revealed on Wednesday, Sept. 15, that the smart gadget’s blood pressure monitoring feature is very useful for patients.
The Samsung Galaxy smartwatches are equipped with various health and fitness features and its blood pressure monitoring was especially found to be beneficial. According to Yonhap News Agency, a study was conducted at the Samsung Medical Center based in Seoul, and researchers found that the BP function in the watch may help people with Parkinson’s disease in terms of effective management of orthostatic hypotension which is a type of low blood pressure typically brought about by blood vessels that failed to constrict.
The study led by Dr. Jin Whan Cho and Dr. Jong Hyeon Ahn has been titled the “Validation of Blood Pressure Measurement Using a Smartwatch in Patients With Parkinson's Disease,” and it was published in Frontiers in Neurology, a medical journal for research reports, in June.
In the report, researchers were said to have compared blood pressure measurement data taken from the Samsung Galaxy Watch3 and the other was measured by using a sphygmomanometer. This was done to compare the accuracy of the results and it showed that both devices yielded similar measurements.
“Orthostatic hypotension is a common and challenging symptom that affects people living with PD. But it is hard to screen just by observing symptoms, and the problem may go undetected when measuring BP,” the research team said in a separate press release that was posted by Samsung. “If we could use a smartwatch to measure patients’ BP regularly and detect potential issues at an early stage, it would really help treat and manage PD.”
The study was carried with the participation of 56 patients who were fitted with Galaxy Watch3 on one arm while the sphygmomanometer was put on the other. All the patients underwent blood measure testing three times, using the two devices.
Meanwhile, Samsung’s smartwatches lineup including Galaxy Watch3, Galaxy Watch Active2, and Galaxy Watch4 all have a blood pressure monitoring feature. The BP is being measured through pulse wave analysis that is tracked with Heart Rate Monitoring sensors.
